GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Galenica Ltd. (XSWX:GALE) » Definitions » Beneish M-Score

Galenica (XSWX:GALE) Beneish M-Score : -2.32 (As of May. 12, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Galenica Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.32 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Galenica's Beneish M-Score or its related term are showing as below:

XSWX:GALE' s Beneish M-Score Range Over the Past 10 Years
Min: -3.06   Med: -2.57   Max: -2.05
Current: -2.32

During the past 11 years, the highest Beneish M-Score of Galenica was -2.05. The lowest was -3.06. And the median was -2.57.


Galenica Beneish M-Score Historical Data

The historical data trend for Galenica's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galenica Beneish M-Score Chart

Galenica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.06 -2.57 -2.56 -2.63 -2.32

Galenica Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.56 - -2.63 - -2.32

Competitive Comparison of Galenica's Beneish M-Score

For the Medical Distribution subindustry, Galenica's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galenica's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Galenica's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Galenica's Beneish M-Score falls into.



Galenica Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Galenica for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9456+0.528 * 0.9875+0.404 * 1.1057+0.892 * 1.0439+0.115 * 0.9945
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1608+4.679 * 0.019946-0.327 * 0.7871
=-2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was CHF560 Mil.
Revenue was CHF3,746 Mil.
Gross Profit was CHF1,042 Mil.
Total Current Assets was CHF1,034 Mil.
Total Assets was CHF2,991 Mil.
Property, Plant and Equipment(Net PPE) was CHF489 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF103 Mil.
Selling, General, & Admin. Expense(SGA) was CHF100 Mil.
Total Current Liabilities was CHF772 Mil.
Long-Term Debt & Capital Lease Obligation was CHF186 Mil.
Net Income was CHF285 Mil.
Gross Profit was CHF0 Mil.
Cash Flow from Operations was CHF226 Mil.
Total Receivables was CHF568 Mil.
Revenue was CHF3,588 Mil.
Gross Profit was CHF985 Mil.
Total Current Assets was CHF977 Mil.
Total Assets was CHF2,613 Mil.
Property, Plant and Equipment(Net PPE) was CHF476 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF100 Mil.
Selling, General, & Admin. Expense(SGA) was CHF82 Mil.
Total Current Liabilities was CHF880 Mil.
Long-Term Debt & Capital Lease Obligation was CHF183 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(560.335 / 3746.011) / (567.632 / 3588.456)
=0.149582 / 0.158183
=0.9456

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(985.298 / 3588.456) / (1041.579 / 3746.011)
=0.274574 / 0.27805
=0.9875

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1033.59 + 489.285) / 2990.952) / (1 - (976.718 + 476.179) / 2612.825)
=0.490839 / 0.443936
=1.1057

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3746.011 / 3588.456
=1.0439

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(99.572 / (99.572 + 476.179)) / (103 / (103 + 489.285))
=0.172943 / 0.173903
=0.9945

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(99.552 / 3746.011) / (82.149 / 3588.456)
=0.026575 / 0.022893
=1.1608

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((185.557 + 772.269) / 2990.952) / ((183.005 + 880.119) / 2612.825)
=0.320241 / 0.406887
=0.7871

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(285.367 - 0 - 225.71) / 2990.952
=0.019946

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Galenica has a M-score of -2.32 suggests that the company is unlikely to be a manipulator.


Galenica Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Galenica's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Galenica (XSWX:GALE) Business Description

Traded in Other Exchanges
Address
Untermattweg 8, Bern, CHE, 3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is primarily operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners and suppliers.

Galenica (XSWX:GALE) Headlines

No Headlines